. "Some proponents of low-dose naltrexone have made unproven or pseudoscientific claims about its efficacy in treating a wide range of diseases, including cancer and HIV. Low-dose naltrexone organizations have promoted its use on their webpages.[2] Neurologist and skeptic Steven Novella has criticized these claims, pointing out a lack of clinical trials supporting them.[3]" . . .